Page 1 | Search Results | Diabetes Care | American Diabetes Association

1-3 of 3

Sort by

Sort Order Select

Journal Articles

Impact of HbA_1c Followed 32 Years From Diagnosis of Type 1 Diabetes on Development of Severe Retinopathy and Nephropathy: The VISS Study

Hans J. Arnqvist, Malin C. Westerlund, Mats Fredrikson, Johnny Ludvigsson, Maria Nordwall

Diabetes Care 2022;45(11):2675–2682

https://doi.org/10.2337/dc22-0239

Published: 12 September 2022

View article titled, Impact of HbA1c Followed 32 Years From Diagnosis of Type 1 Diabetes on Development of Severe Retinopathy and Nephropathy: The VISS Study

Journal Articles

Response to Comment on Nordwall et al. Impact of HbA_1c, Followed From Onset of Type 1 Diabetes, on the Development of Severe Retinopathy and Nephropathy: The VISS Study (Vascular Diabetic Complications in Southeast Sweden). Diabetes Care 2015;38:308–315

Maria Nordwall, Mariann Abrahamsson, Meryl Dhir, Mats Fredrikson, Johnny Ludvigsson, Hans J. Arnqvist

Diabetes Care 2015;38(8):e124

https://doi.org/10.2337/dc15-0939

Published: 14 July 2015

View article titled, Response to Comment on Nordwall et al. Impact of HbA1c, Followed From Onset of Type 1 Diabetes, on the Development of Severe Retinopathy and Nephropathy: The VISS Study (Vascular Diabetic Complications in Southeast Sweden). Diabetes Care 2015;38:308–315

Journal Articles

Impact of HbA_1c, Followed From Onset of Type 1 Diabetes, on the Development of Severe Retinopathy and Nephropathy: The VISS Study (Vascular Diabetic Complications in Southeast Sweden)

Maria Nordwall, Mariann Abrahamsson, Meryl Dhir, Mats Fredrikson, Johnny Ludvigsson, Hans J. Arnqvist

Diabetes Care 2015;38(2):308–315

https://doi.org/10.2337/dc14-1203

Published: 15 December 2014

View article titled, Impact of HbA1c, Followed From Onset of Type 1 Diabetes, on the Development of Severe Retinopathy and Nephropathy: The VISS Study (Vascular Diabetic Complications in Southeast Sweden)

Includes: Supplementary data

NARROW

Impact of HbA_1c Followed 32 Years From Diagnosis of Type 1 Diabetes on Development of Severe Retinopathy and Nephropathy: The VISS Study

Response to Comment on Nordwall et al. Impact of HbA_1c, Followed From Onset of Type 1 Diabetes, on the Development of Severe Retinopathy and Nephropathy: The VISS Study (Vascular Diabetic Complications in Southeast Sweden). Diabetes Care 2015;38:308–315

Impact of HbA_1c, Followed From Onset of Type 1 Diabetes, on the Development of Severe Retinopathy and Nephropathy: The VISS Study (Vascular Diabetic Complications in Southeast Sweden)

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Impact of HbA1c Followed 32 Years From Diagnosis of Type 1 Diabetes on Development of Severe Retinopathy and Nephropathy: The VISS Study

Response to Comment on Nordwall et al. Impact of HbA1c, Followed From Onset of Type 1 Diabetes, on the Development of Severe Retinopathy and Nephropathy: The VISS Study (Vascular Diabetic Complications in Southeast Sweden). Diabetes Care 2015;38:308–315

Impact of HbA1c, Followed From Onset of Type 1 Diabetes, on the Development of Severe Retinopathy and Nephropathy: The VISS Study (Vascular Diabetic Complications in Southeast Sweden)

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only

Impact of HbA_1c Followed 32 Years From Diagnosis of Type 1 Diabetes on Development of Severe Retinopathy and Nephropathy: The VISS Study

Response to Comment on Nordwall et al. Impact of HbA_1c, Followed From Onset of Type 1 Diabetes, on the Development of Severe Retinopathy and Nephropathy: The VISS Study (Vascular Diabetic Complications in Southeast Sweden). Diabetes Care 2015;38:308–315

Impact of HbA_1c, Followed From Onset of Type 1 Diabetes, on the Development of Severe Retinopathy and Nephropathy: The VISS Study (Vascular Diabetic Complications in Southeast Sweden)